GlassScriptPhysician profile
Randall P Johnson
NPI 1407338627
$1,172.42
in general payments reported to CMS, 2019-2025
17 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.38 · 2022: $45.78 · 2023: $42.64 · 2024: $21.65 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $335.67 | 2021-2025 | |
| Pfizer INC. | $131.97 | 2021-2025 | |
| Eisai INC. | $91.25 | 2025 | |
| Ucb, INC. | $81.30 | 2025 | Nayzilam |
| Tg Therapeutics, INC. | $79.45 | 2025 | |
| Novartis Pharmaceuticals Corporation | $75.01 | 2025 | |
| Sk Life Science, INC. | $53.41 | 2025 | |
| Genentech USA, INC. | $52.74 | 2025 | Ocrevus Zunovo |
| Lundbeck LLC | $48.47 | 2025 | Vyepti |
| Alkermes, INC. | $47.82 | 2023-2024 | Vivitrol, Vivitrol |
| Lilly USA, LLC | $38.39 | 2025 | Kisunla, Amyvid |
| Melinta Therapeutics, LLC | $31.51 | 2021 | |
| Aucta Pharmaceuticals, INC. | $26.77 | 2025 | Motpoly Xr |
| Dynasplint Systems INC. | $25.33 | 2025 | Dynasplint |
| Acadia Pharmaceuticals INC | $21.79 | 2025 | Nuplazid |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $19.35 | 2025 | Valtoco |
| Janssen Pharmaceuticals, INC | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.